7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Scopus BioPharma Inc
(NASDAQ:SCPS) 

SCPS stock logo

Scopus BioPharma Inc., a biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Its lead development programs are immuno-oncology gene therapy for the treatment of various cancers, which include CO-sTiRNA, a STAT3 inhibitor gene therapy that drives...

Founded: 2017
Full Time Employees: 1 (May 2021)
CEO: Joshua R. Lamstein  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Scopus BioPharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.02-0.87-0.73-0.58-0.44-0.29-0.150
Scopus BioPharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1.02-0.87-0.73-0.58-0.44-0.29-0.150
Scopus BioPharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.010.020.020.030.040.050.05
Scopus BioPharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.39-0.33-0.28-0.22-0.17-0.11-0.060
Scopus BioPharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.03-1.74-1.45-1.16-0.87-0.58-0.290
No extra charts and metrics for this ticker.